Valuation Theraclion Deutsche Boerse AG
Stocks
941
FR0010120402
Advanced Medical Equipment & Technology
|
Delayed
Deutsche Boerse AG
10:01:30 26/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.5940 EUR | -1.00% |
|
-1.00% | - |
| 07-24 | Theraclion SA Reports Consolidated Revenue Results for the First Half Ended June 30, 2026 | CI |
| 07-09 | Theraclion Announces Board Changes | CI |
Company Valuation: Theraclion
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 30.8 | 29.81 | 26.15 | 17.18 | 15.24 | 28.28 |
| Change | - | -3.22% | -12.29% | -34.28% | -11.33% | 85.64% |
| Enterprise Value (EV) 1 | 39.07 | 36.8 | 32.67 | 17.6 | 18.65 | 36.14 |
| Change | - | -5.81% | -11.22% | -46.11% | 5.92% | 93.8% |
| P/E | -8.37x | -7.93x | -5.35x | -5.1x | -2.66x | -6.33x |
| PBR | -10.1x | -23.4x | 48.7x | 3.14x | -165,500x | -13.9x |
| PEG | - | 0.3x | -2.34x | 0.1x | -0x | 0.3x |
| Capitalization / Revenue | 41.4x | 20.1x | 21.2x | 9.43x | 18.4x | 43.4x |
| EV / Revenue | 52.5x | 24.8x | 26.4x | 9.66x | 22.5x | 55.4x |
| EV / EBITDA | -9.42x | -8.35x | -5.3x | -5.83x | -2.87x | -4.92x |
| EV / EBIT | -9.11x | -8.11x | -5.18x | -5.58x | -2.73x | -4.67x |
| EV / FCF | -12.2x | -13.7x | -6.8x | -4.95x | -76.9x | -5.75x |
| FCF Yield | -8.17% | -7.31% | -14.7% | -20.2% | -1.3% | -17.4% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.2414 | -0.1652 | -0.1689 | -0.0761 | -0.1244 | -0.0951 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 0.744 | 1.481 | 1.235 | 1.822 | 0.8302 | 0.652 |
| EBITDA 1 | -4.15 | -4.405 | -6.163 | -3.021 | -6.498 | -7.347 |
| EBIT 1 | -4.288 | -4.535 | -6.307 | -3.153 | -6.819 | -7.746 |
| Net income 1 | -3.905 | -3.76 | -4.964 | -3.675 | -5.757 | -5.69 |
| Net Debt 1 | 8.266 | 6.988 | 6.523 | 0.4215 | 3.411 | 7.852 |
| Reference price 2 | 2.0200 | 1.3100 | 0.9040 | 0.3880 | 0.3310 | 0.6020 |
| Nbr of stocks (in thousands) | 15,249 | 22,757 | 28,925 | 44,287 | 46,031 | 46,985 |
| Announcement Date | 29/04/22 | 29/04/22 | 29/04/23 | 25/04/24 | 05/05/25 | 17/04/26 |
1EUR in Million2EUR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 31.28x | 5.51x | 21.14x | 0.29% | 232B | |
| 36.43x | 6.54x | 20.73x | 0.66% | 152B | |
| 40.78x | 10.6x | 23.43x | -.--% | 131B | |
| 18.61x | 3.79x | 12.3x | -.--% | 72.26B | |
| 19.67x | 2.36x | 11.79x | 2.59% | 51.57B | |
| 35.91x | 7.21x | 22.81x | -.--% | 52.38B | |
| 30.1x | 6x | 20.58x | 0.66% | 43.71B | |
| 72.56x | 6.92x | 21.07x | -.--% | 40.72B | |
| 45.46x | 7.4x | 26.11x | -.--% | 33.97B | |
| Average | 36.76x | 6.26x | 19.99x | 0.47% | 90.01B | |
| Weighted average by Cap. | 34.82x | 6.46x | 20.33x | 0.41% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALTHE Stock
- 941 Stock
- Valuation Theraclion
Select your edition
All financial news and data tailored to specific country editions
